190 related articles for article (PubMed ID: 26549579)
1. A quantitative review of the postmortem evidence for decreased cortical N-methyl-D-aspartate receptor expression levels in schizophrenia: How can we link molecular abnormalities to mismatch negativity deficits?
Catts VS; Lai YL; Weickert CS; Weickert TW; Catts SV
Biol Psychol; 2016 Apr; 116():57-67. PubMed ID: 26549579
[TBL] [Abstract][Full Text] [Related]
2. Mice with subtle reduction of NMDA NR1 receptor subunit expression have a selective decrease in mismatch negativity: Implications for schizophrenia prodromal population.
Featherstone RE; Shin R; Kogan JH; Liang Y; Matsumoto M; Siegel SJ
Neurobiol Dis; 2015 Jan; 73():289-95. PubMed ID: 25461194
[TBL] [Abstract][Full Text] [Related]
3. Intracortical mechanisms of mismatch negativity dysfunction in schizophrenia.
Javitt DC
Audiol Neurootol; 2000; 5(3-4):207-15. PubMed ID: 10859415
[TBL] [Abstract][Full Text] [Related]
4. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia.
Dracheva S; Marras SA; Elhakem SL; Kramer FR; Davis KL; Haroutunian V
Am J Psychiatry; 2001 Sep; 158(9):1400-10. PubMed ID: 11532724
[TBL] [Abstract][Full Text] [Related]
5. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics.
Akbarian S; Sucher NJ; Bradley D; Tafazzoli A; Trinh D; Hetrick WP; Potkin SG; Sandman CA; Bunney WE; Jones EG
J Neurosci; 1996 Jan; 16(1):19-30. PubMed ID: 8613785
[TBL] [Abstract][Full Text] [Related]
6. Mismatch responses and deviance detection in N-methyl-D-aspartate (NMDA) receptor hypofunction and developmental models of schizophrenia.
Harms L
Biol Psychol; 2016 Apr; 116():75-81. PubMed ID: 26159809
[TBL] [Abstract][Full Text] [Related]
7. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia.
Gao XM; Sakai K; Roberts RC; Conley RR; Dean B; Tamminga CA
Am J Psychiatry; 2000 Jul; 157(7):1141-9. PubMed ID: 10873924
[TBL] [Abstract][Full Text] [Related]
8. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
Beneyto M; Meador-Woodruff JH
Neuropsychopharmacology; 2008 Aug; 33(9):2175-86. PubMed ID: 18033238
[TBL] [Abstract][Full Text] [Related]
9. NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder.
Mueller HT; Meador-Woodruff JH
Schizophr Res; 2004 Dec; 71(2-3):361-70. PubMed ID: 15474907
[TBL] [Abstract][Full Text] [Related]
10. Synaptic interactions and inhibitory regulation in auditory cortex.
Askew CE; Metherate R
Biol Psychol; 2016 Apr; 116():4-9. PubMed ID: 26555718
[TBL] [Abstract][Full Text] [Related]
11. [Mismatch negativity in schizophrenia research. An indicator of early processing disorders of acoustic information].
Rosburg T; Kreitschmann-Andermahr I; Sauer H
Nervenarzt; 2004 Jul; 75(7):633-41. PubMed ID: 14999460
[TBL] [Abstract][Full Text] [Related]
12. Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.
McCullumsmith RE; Kristiansen LV; Beneyto M; Scarr E; Dean B; Meador-Woodruff JH
Brain Res; 2007 Jan; 1127(1):108-18. PubMed ID: 17113057
[TBL] [Abstract][Full Text] [Related]
13. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia.
Kristiansen LV; Beneyto M; Haroutunian V; Meador-Woodruff JH
Mol Psychiatry; 2006 Aug; 11(8):737-47, 705. PubMed ID: 16702973
[TBL] [Abstract][Full Text] [Related]
14. Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.
Weickert CS; Fung SJ; Catts VS; Schofield PR; Allen KM; Moore LT; Newell KA; Pellen D; Huang XF; Catts SV; Weickert TW
Mol Psychiatry; 2013 Nov; 18(11):1185-92. PubMed ID: 23070074
[TBL] [Abstract][Full Text] [Related]
15. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function.
Duncan GE; Moy SS; Perez A; Eddy DM; Zinzow WM; Lieberman JA; Snouwaert JN; Koller BH
Behav Brain Res; 2004 Aug; 153(2):507-19. PubMed ID: 15265649
[TBL] [Abstract][Full Text] [Related]
16. The effects of ketamine on the mismatch negativity (MMN) in humans - A meta-analysis.
Rosburg T; Kreitschmann-Andermahr I
Clin Neurophysiol; 2016 Feb; 127(2):1387-1394. PubMed ID: 26699665
[TBL] [Abstract][Full Text] [Related]
17. NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia.
Ramsey AJ
Prog Brain Res; 2009; 179():51-8. PubMed ID: 20302817
[TBL] [Abstract][Full Text] [Related]
18. A predictive coding account of MMN reduction in schizophrenia.
Wacongne C
Biol Psychol; 2016 Apr; 116():68-74. PubMed ID: 26582536
[TBL] [Abstract][Full Text] [Related]
19. Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M
Grannan MD; Mielnik CA; Moran SP; Gould RW; Ball J; Lu Z; Bubser M; Ramsey AJ; Abe M; Cho HP; Nance KD; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW; Jones CK
ACS Chem Neurosci; 2016 Dec; 7(12):1706-1716. PubMed ID: 27617634
[TBL] [Abstract][Full Text] [Related]
20. The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.
Ju P; Cui D
Acta Biochim Biophys Sin (Shanghai); 2016 Mar; 48(3):209-19. PubMed ID: 26837414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
